Australia
· Delayed Price · Currency is AUD 4DMedical Statistics
Total Valuation
4DMedical has a market cap or net worth of AUD 234.40 million. The enterprise value is 208.92 million.
| Market Cap | 234.40M |
| Enterprise Value | 208.92M |
Important Dates
The next estimated earnings date is Wednesday, February 26, 2025.
| Earnings Date | Feb 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
4DMedical has 411.23 million shares outstanding. The number of shares has increased by 23.49% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 411.23M |
| Shares Change (YoY) | +23.49% |
| Shares Change (QoQ) | -0.60% |
| Owned by Insiders (%) | 4.07% |
| Owned by Institutions (%) | 1.35% |
| Float | 323.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 56.25 |
| PB Ratio | 3.30 |
| P/TBV Ratio | 89.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.81 |
| EV / Sales | 55.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.73 |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.07.
| Current Ratio | 1.78 |
| Quick Ratio | 1.67 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.17 |
| Interest Coverage | -173.91 |
Financial Efficiency
Return on equity (ROE) is -50.54% and return on invested capital (ROIC) is -37.59%.
| Return on Equity (ROE) | -50.54% |
| Return on Assets (ROA) | -26.95% |
| Return on Capital (ROIC) | -37.59% |
| Revenue Per Employee | 25,891 |
| Profits Per Employee | -248,129 |
| Employee Count | 145 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 0.29 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.87% in the last 52 weeks. The beta is 1.34, so 4DMedical's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | -8.87% |
| 50-Day Moving Average | 0.49 |
| 200-Day Moving Average | 0.51 |
| Relative Strength Index (RSI) | 61.73 |
| Average Volume (20 Days) | 1,464,002 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, 4DMedical had revenue of AUD 3.75 million and -35.98 million in losses. Loss per share was -0.11.
| Revenue | 3.75M |
| Gross Profit | 3.52M |
| Operating Income | -45.91M |
| Pretax Income | -35.93M |
| Net Income | -35.98M |
| EBITDA | -44.75M |
| EBIT | -45.91M |
| Loss Per Share | -0.11 |
Balance Sheet
The company has 30.61 million in cash and 5.12 million in debt, giving a net cash position of 25.49 million or 0.06 per share.
| Cash & Cash Equivalents | 30.61M |
| Total Debt | 5.12M |
| Net Cash | 25.49M |
| Net Cash Per Share | 0.06 |
| Equity (Book Value) | 70.93M |
| Book Value Per Share | 0.17 |
| Working Capital | 17.16M |
Cash Flow
In the last 12 months, operating cash flow was -30.87 million and capital expenditures -156,109, giving a free cash flow of -31.02 million.
| Operating Cash Flow | -30.87M |
| Capital Expenditures | -156,109 |
| Free Cash Flow | -31.02M |
| FCF Per Share | -0.08 |
Margins
| Gross Margin | 93.69% |
| Operating Margin | -1,222.75% |
| Pretax Margin | -957.05% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
4DMedical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.49% |
| Shareholder Yield | -23.49% |
| Earnings Yield | -19.30% |
| FCF Yield | -13.23% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
4DMedical has an Altman Z-Score of 0.06. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.06 |
| Piotroski F-Score | n/a |